Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
The present invention relates to substituted heteroarylpiperidine derivative (I) as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TERINEK, MIROSLAV DEPPE, HOLGER HERZNER, HOLGER RUMMEY, CHRISTIAN FEURER, ACHIM HENNEBOHLE, MARCO SIENDT, HERVE WEYERMANN, PHILIPP SOEBERDT, MICHAEL NORDHOFF, SONJA |
| description | The present invention relates to substituted heteroarylpiperidine derivative (I) as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amyotrophic lateral sclerosis (ALS), anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2008277916BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2008277916BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2008277916BB23</originalsourceid><addsrcrecordid>eNqNyr0KwjAUhuEsDqLeQwbXQo1idbSiOPszl2PyiYE0CclJwbu3gxfg9D7DOxXXW3lmtlwYRr7BSIHSx0UbkayxHtKMGIjtgCwpyx6OfNAhsfXVRiZoRA5J9sEUR6PyXExe5DIWv87E8ny6Hy8VYuiQI2l4cHd4qLreqabZr7Ztq9Z_bl9GhTsD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators</title><source>esp@cenet</source><creator>TERINEK, MIROSLAV ; DEPPE, HOLGER ; HERZNER, HOLGER ; RUMMEY, CHRISTIAN ; FEURER, ACHIM ; HENNEBOHLE, MARCO ; SIENDT, HERVE ; WEYERMANN, PHILIPP ; SOEBERDT, MICHAEL ; NORDHOFF, SONJA</creator><creatorcontrib>TERINEK, MIROSLAV ; DEPPE, HOLGER ; HERZNER, HOLGER ; RUMMEY, CHRISTIAN ; FEURER, ACHIM ; HENNEBOHLE, MARCO ; SIENDT, HERVE ; WEYERMANN, PHILIPP ; SOEBERDT, MICHAEL ; NORDHOFF, SONJA</creatorcontrib><description>The present invention relates to substituted heteroarylpiperidine derivative (I) as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amyotrophic lateral sclerosis (ALS), anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120202&DB=EPODOC&CC=AU&NR=2008277916B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120202&DB=EPODOC&CC=AU&NR=2008277916B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TERINEK, MIROSLAV</creatorcontrib><creatorcontrib>DEPPE, HOLGER</creatorcontrib><creatorcontrib>HERZNER, HOLGER</creatorcontrib><creatorcontrib>RUMMEY, CHRISTIAN</creatorcontrib><creatorcontrib>FEURER, ACHIM</creatorcontrib><creatorcontrib>HENNEBOHLE, MARCO</creatorcontrib><creatorcontrib>SIENDT, HERVE</creatorcontrib><creatorcontrib>WEYERMANN, PHILIPP</creatorcontrib><creatorcontrib>SOEBERDT, MICHAEL</creatorcontrib><creatorcontrib>NORDHOFF, SONJA</creatorcontrib><title>Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators</title><description>The present invention relates to substituted heteroarylpiperidine derivative (I) as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amyotrophic lateral sclerosis (ALS), anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAUhuEsDqLeQwbXQo1idbSiOPszl2PyiYE0CclJwbu3gxfg9D7DOxXXW3lmtlwYRr7BSIHSx0UbkayxHtKMGIjtgCwpyx6OfNAhsfXVRiZoRA5J9sEUR6PyXExe5DIWv87E8ny6Hy8VYuiQI2l4cHd4qLreqabZr7Ztq9Z_bl9GhTsD</recordid><startdate>20120202</startdate><enddate>20120202</enddate><creator>TERINEK, MIROSLAV</creator><creator>DEPPE, HOLGER</creator><creator>HERZNER, HOLGER</creator><creator>RUMMEY, CHRISTIAN</creator><creator>FEURER, ACHIM</creator><creator>HENNEBOHLE, MARCO</creator><creator>SIENDT, HERVE</creator><creator>WEYERMANN, PHILIPP</creator><creator>SOEBERDT, MICHAEL</creator><creator>NORDHOFF, SONJA</creator><scope>EVB</scope></search><sort><creationdate>20120202</creationdate><title>Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators</title><author>TERINEK, MIROSLAV ; DEPPE, HOLGER ; HERZNER, HOLGER ; RUMMEY, CHRISTIAN ; FEURER, ACHIM ; HENNEBOHLE, MARCO ; SIENDT, HERVE ; WEYERMANN, PHILIPP ; SOEBERDT, MICHAEL ; NORDHOFF, SONJA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2008277916BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TERINEK, MIROSLAV</creatorcontrib><creatorcontrib>DEPPE, HOLGER</creatorcontrib><creatorcontrib>HERZNER, HOLGER</creatorcontrib><creatorcontrib>RUMMEY, CHRISTIAN</creatorcontrib><creatorcontrib>FEURER, ACHIM</creatorcontrib><creatorcontrib>HENNEBOHLE, MARCO</creatorcontrib><creatorcontrib>SIENDT, HERVE</creatorcontrib><creatorcontrib>WEYERMANN, PHILIPP</creatorcontrib><creatorcontrib>SOEBERDT, MICHAEL</creatorcontrib><creatorcontrib>NORDHOFF, SONJA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TERINEK, MIROSLAV</au><au>DEPPE, HOLGER</au><au>HERZNER, HOLGER</au><au>RUMMEY, CHRISTIAN</au><au>FEURER, ACHIM</au><au>HENNEBOHLE, MARCO</au><au>SIENDT, HERVE</au><au>WEYERMANN, PHILIPP</au><au>SOEBERDT, MICHAEL</au><au>NORDHOFF, SONJA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators</title><date>2012-02-02</date><risdate>2012</risdate><abstract>The present invention relates to substituted heteroarylpiperidine derivative (I) as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amyotrophic lateral sclerosis (ALS), anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2008277916BB2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T19%3A09%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TERINEK,%20MIROSLAV&rft.date=2012-02-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2008277916BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |